[BioAsia Satellite Symposia 2026] The Future of Acclerating Drug Discovery 藥物發現與非動物替代模型的新世代

Synopsis | 概要

藥物發現正迎來 human-relevant models 百花齊放的關鍵時刻。多年來累積的 iPSC、類器官、3D 細胞模型、自動化培養、高通量分析與 AI 影像/功能分析技術，正在從單點突破走向可整合、可重現、可擴展的應用流程。NAM 與 3R 的發展不只是政策趨勢，更代表生醫研究工具正在成熟到能夠真正支援標靶發現、候選藥物評估與臨床前驗證的新階段。

本次 BioAsia 2026 衛星論壇將串聯政策視野、國家級平台服務、臨床相關腫瘤類器官、iPSC-based 3D models、AI 驅動的自動化工作流與 endpoint analysis，協助與會者看見這些技術如何從模型建立、智慧化培養、影像與功能讀值，到資料解讀與決策支援，形成更貼近人體生理的藥物探索路徑。論壇不只介紹技術亮點，更聚焦如何讓這些工具進入真實研發流程。

參與本論壇，您將掌握非動物替代模型與下一代藥物探索平台的最新發展脈絡，理解不同技術在癌症研究、轉譯醫學、藥物開發與平台建置中的應用價值，並與 NAM、3R、類器官、自動化與高通量分析領域的專家交流合作機會。這是一場為生命科學研究者、新藥研發團隊與生醫創新決策者設計的前瞻論壇。

Drug discovery is entering a pivotal moment where human-relevant models are moving from scientific promise into practical application. Years of progress in iPSC technology, organoids, 3D cell models, automated culture, high-throughput analysis, and AI-enabled imaging and functional analysis are converging into workflows that are increasingly integrated, reproducible, and scalable. The rise of NAM and 3R is not only a policy signal, but also a reflection that next-generation biomedical research tools are reaching the maturity needed to support target discovery, candidate evaluation, and preclinical validation.

The BioAsia 2026 Satellite Symposium will connect policy perspective, national platform services, clinically relevant tumor organoids, iPSC-based 3D models, AI-driven automated workflows, and endpoint analysis. The session will help attendees see how these technologies can form a more human-relevant discovery path, from model generation and intelligent culture automation to imaging, functional readouts, data interpretation, and decision support. Beyond introducing technical highlights, the symposium will focus on how these tools can be translated into real R&D workflows.

By joining this symposium, attendees will gain a clear view of the latest momentum in non-animal alternative models and next-generation drug discovery platforms. Participants will better understand how different technologies create value in cancer research, translational medicine, drug development, and platform strategy, while connecting with experts across NAM, 3R, organoids, automation, and high-throughput analysis. This forum is designed for life science researchers, drug discovery teams, and biomedical innovation decision-makers looking to capture the next wave of practical innovation.

Topics | 主題

【活動註記 | Event Note】

• 本活動為「預約審核制」，成功獲邀者可免費入場。主辦方有權對於報名人進行優先排序及最終參加的決定權。活動為科學專業論壇，將優先提供相關背景及領域的專業人士參與。

• This event operates on a “reservation and review system.” Those who successfully receive an invitation can enter for free. The organizers reserve the right to prioritize applicants and make the final decision on participation. The event is a scientific professional forum, and priority will be given to professionals with relevant backgrounds and fields.

• 本活動主辦單位尊重並保護所有報名者的個人資料。您所提供的所有資料將僅用於本次活動的報名和相關事宜，並遵守《中華民國個人資料保護法》及相關法規，妥善保管您的個人資料。

• The organizers of this event respect and protect the personal data of all registrants. All the information you provide will only be used for registration and related matters for this event. We comply with the Personal Data Protection Act and related regulations, and will properly safeguard your personal data.

資料收集目的：本活動報名及後續活動通知。
Purpose of Data Collection: Registration for this event and notifications for subsequent activities.

資料類型：姓名、聯絡方式、電子郵件等。
Type of Data: Name, contact information, email, etc.

資料使用範圍：僅限於本活動主辦單位。
Scope of Data Use: Limited to the organizers of this event.

您的權利：您有權要求查詢、更正或刪除您的個人資料。
Your Rights: You have the right to inquire, correct, or delete your personal data.

若您選擇不提供必要資料，可能會影響您報名本活動的資格。
If you choose not to provide necessary information, it may affect your eligibility to register for this event.
 

主辦單位：